Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Orpha-Devel Handels und Vertriebs GmbH, Wintergasse 85/1B, A-3002 Purkersdorf, Austria
ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for concentrate for solution for infusion. The powder is white to almost white. |
A vial of 50 ml contains 2500 mg esmolol hydrochloride.
Each ml of reconstituted concentrate for solution for infusion contains 50 mg esmolol hydrochloride (50 mg/ml).
Each ml of the diluted solution for infusion contains 10 mg esmolol hydrochloride (10 mg/ml).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Esmolol |
Esmolol is a beta-selective (cardioselective) receptor blocking agent. At therapeutic doses esmolol has no significant intrinsic sympathicomimetic activity (ISA) or membrane stabilising activity. |
| List of Excipients |
|---|
|
None. |
A clear, colourless, 50 ml glass vial with a bromobutyl rubber stopper and a flip off seal containing 2500 mg powder for concentrate for solution for infusion. The vial is packed in an outer cardboard carton.
Pack size: 1 vial per carton.
Orpha-Devel Handels und Vertriebs GmbH, Wintergasse 85/1B, A-3002 Purkersdorf, Austria
PL 30414/0008
Date of first authorisation: 04/10/2010
| Drug | Countries | |
|---|---|---|
| ESMOLOL | Austria, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
